Skip to content

WALKCAST (Comparative evaluation of offloading WALKers and CAST devices in diabetic foot)

Effectiveness of Offloading Devices in Reducing Plantar Pressures and User-Related Outcomes in Diabetic Foot Complications: A Comparative Study - WALKCAST

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58437
Enrollment
50
Registered
2025-07-15
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes-related foot ulcer, diabetic foot ulcer (DFU), Charcot neuro-osteoarthropathy (CNO), Charcot foot, diabetic foot complications. Foot wound due to diabetes, Charcot foot (a diabetes complication where the foot becomes deformed), foot problems caused by diabetes.

Interventions

Participants will trial four below-knee offloading devices used in diabetic foot care:• Total Contact Cast (TCC) – a clinician-applied, non-removable cast constructed from standard materials (stockine

Sponsors

St. Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosed with type 1 or type 2 diabetesAged 18 years or olderConfirmed loss of protective sensation (LOPS) due to peripheral neuropathyOne of the following clinical presentations: – History of a healed plantar diabetic foot ulcer within the past two years – Inactive CNO confirmed by clinical and imaging criteria, with or without midfoot deformity

Exclusion criteria

Exclusion criteria: Active diabetic foot ulceration at the time of recruitmentActive Charcot neuro-osteoarthropathy (clinical and/or radiological evidence)Severe peripheral arterial disease, defined as ankle-brachial index < 0.75 or toe pressure < 30 mmHgHistory of major foot amputation (proximal to the midfoot)Presence of other neuropathic syndromes or non-diabetes-related musculoskeletal conditions (e.g. stroke-related hemiparesis, spasticity, or structural deformities unrelated to diabetes) that are likely to confound plantar pressure measurementsAny medical or cognitive condition that would limit ability to participate in study procedures safely

Design outcomes

Primary

MeasureTime frame
The primary outcome is peak plantar pressure (kPa) measured during standardised walking trials. The main study variable is the difference in peak plantar pressure between offloading devices, compared within the same participant. Lower peak plantar pressure indicates greater offloading effectiveness.

Secondary

MeasureTime frame
Secondary outcomes include participant-reported comfort, usability, satisfaction, and overall preference for each offloading device. Exploratory analyses will compare peak plantar pressure outcomes between clinical subgroups: participants with a history of healed plantar diabetic foot ulceration, inactive Charcot neuro-osteoarthropathy (CNO) with midfoot deformity, and inactive CNO without deformity. Descriptive baseline characteristics, including demographic and diabetes-related variables, will also be collected to support interpretation of outcomes.

Countries

Netherlands

Contacts

Public ContactVEL Milbourn

Amsterdam UMC

v.e.l.milbourn@amsterdamumc.nl0616838828

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026